eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | eosinophilia |
| Comorbidity | C0015230|rash |
| Sentences | 131 |
| PubMedID- 26120548 | A case of drug rash with eosinophilia and systemic symptoms (dress) syndrome under cilostazol and carbamazepine treatment has been published; dress resolved following discontinuation of both drugs and could be reproduced by challenge tests with the individual substances at a 4-week interval. |
| PubMedID- 24843805 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome, also known as drug induced hypersensitivity syndrome (dihs), is a type of adverse drug reaction, which is a severe life threatening systemic disease that should be differentiated from stevens-johnson syndrome and toxic epidermal necrolysis.1,2 the primary clinical manifestations are fever, lymphadenopathy, rash, hypereosinophilia, and involvement of systemic organs. |
| PubMedID- 23075643 | Aim: to determine the prevalence, the clinical patterns of drug eruptions, and the common drugs implicated, particularly in severe cadr such as stevens-johnson syndrome/toxic epidermal necrolysis (sjs/ten) and drug rash with eosinophilia and systemic symptoms (dress) in our population. |
| PubMedID- 24014920 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is an adverse reaction commonly occurring with antiepileptic agents. |
| PubMedID- 23882307 | It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate. |
| PubMedID- 21098750 | Objective: to report a case of lamotrigine-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome with pancreatitis as the initial visceral involvement. |
| PubMedID- 26418832 | The third case of vemurafenib-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome is reported herein. |
| PubMedID- 23114284 | We describe 11 cases of anti-tuberculosis dress (drug-related rash with eosinophilia and systemic symptoms) syndrome, a potentially serious complication of treatment that led to interruption of treatment for prolonged periods, systemic corticosteroid use and the resumption of treatment with less effective regimens. |
| PubMedID- 23455629 | No cases of hypersensitivity reactions, such as drug rash with eosinophilia and systemic symptoms (dress), steven-johnson syndrome, or toxic epidermal necrolysis, were reported. |
| PubMedID- 21361742 | The life-threatening dress (drug rash with eosinophilia and systemic symptoms) syndrome is characterized by the presence of at least three of the following findings: fever, exanthema, eosinophilia, atypical circulating lymphocytes, lymphadenopathy, and hepatitis. |
| PubMedID- 20358021 | Similar to patch tests, ltt are often positive in mpe, bullous exanthema, agep, and drug rash with eosinophilia and systemic symptoms (dress). |
| PubMedID- 23248384 | The syndrome is commonly referred to as either drug rash with eosinophilia and systemic symptoms (dress) or dhs. |
| PubMedID- 23551241 | Background: aromatic anticonvulsant-induced severe cutaneous adverse drug reactions (scars), including stevens-johnson syndrome (sjs), toxic epidermal necrosis (ten), and drug rash with eosinophilia and systemic symptoms (dress), are fatal immune-mediated adverse drug reactions. |
| PubMedID- 24450829 | Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man. |
| PubMedID- 24479051 | Drug rash with eosinophilia and systemic symptoms syndrome due to anti-tb medication. |
| PubMedID- 21103811 | Eight different clinical reaction patterns were noted, namely drug exanthems (46.4 percent), drug rash with eosinophilia and systemic symptoms (18.6 percent), stevens-johnson syndrome/toxic epidermal necrolysis spectrum (14.4 percent), urticaria/angioedema (11.3 percent), acute generalised exanthematous pustulosis (3.1 percent), fixed drug eruptions (3.1 percent), generalised exfoliative dermatitis (2.1 percent) and drug-induced vasculitis (1.0 percent). |
| PubMedID- 24687387 | However, severe cutaneous adverse drug reactions have been reported, such as drug rash with eosinophilia and systemic symptoms (dress), stevens-johnson syndrome (sjs), and toxic epidermal necrolysis (ten). |
| PubMedID- 23575622 | Cases description: we report two cases of drug rash with eosinophilia and systemic symptoms (dress) associated with the use of carbamazepine and phenytoin in brazilian boys tested for human leukocyte antigen (hla) class i and ii alleles. |
| PubMedID- 25114941 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is a drug reaction commonly occurring in association with aromatic anticonvulsants and allopurinol. |
| PubMedID- 22162933 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterized by cutaneous drug eruption, eosinophilia, and systemic symptoms (lymphadenopathy, hepatitis, interstitial nephritis, interstitial pneumonitis, and/or carditis).1 this paper describes a patient with dress syndrome caused by allopurinol, the clinical presentation of which mimicked community-acquired pneumonia. |
| PubMedID- 20798484 | We report a case of drug rash with eosinophilia and systemic symptoms (dress) due to telaprevir (vx-950), a specific inhibitor of the hepatitis c virus (hcv) serine protease. |
| PubMedID- 25986261 | Isoniazid-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome presenting as acute eosinophilic myocarditis. |
| PubMedID- 21852061 | Background: drug rash with eosinophilia and systemic symptoms (dress) syndrome is an uncommon but serious hypersensitivity drug reaction most frequently associated with antiepileptics. |
| PubMedID- 25234569 | Drug rash with eosinophilia and systemic symptoms is a drug hypersensitivity reaction. |
| PubMedID- 25422656 | The severe types (sjs, ten, drug rash with eosinophilia and systemic symptoms and overlap syndrome) were more frequent in the patients aged |
| PubMedID- 20358026 | Purpose: drug rash with eosinophilia and systemic symptoms (dress) and the stevens-johnson syndrome (sjs) are both severe drug reactions. |
| PubMedID- 24749495 | Abbreviations: ap, anaphylactoid purpura; dihs, drug‐induced hypersensitivity syndrome; dress, drug rash with eosinophilia and systemic symptoms; e/d, eczema/dermatitis; sjs, stevens–johnson syndrome; ten, toxic epidermal necrolysis. |
| PubMedID- 23829691 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome and hepatitis induced by phenytoin. |
| PubMedID- 20136879 | Its value in drug rash with eosinophilia and systemic symptoms (dress) has not been established in a large cohort of patients. |
| PubMedID- 21217791 | Drug rash with eosinophilia and systemic symptoms (dress) after an unrelated donor bm transplant. |
| PubMedID- 21072291 | During post–marketing surveillance, isolated cases of hypersensitivity syndrome or drug rash with eosinophilia and systemic symptoms have been reported. |
| PubMedID- 20846239 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome induced by cidofovir. |
| PubMedID- 22611746 | Drug rash with eosinophilia and systemic symptoms (dress syndrome). |
| PubMedID- 26416594 | Such reactions can manifest as a rash combined with eosinophilia, leukocytosis, fever, hepatitis and progressive kidney failure. |
| PubMedID- 20103499 | Drug rash with eosinophilia and systemic symptoms (dress): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of dress. |
| PubMedID- 22271506 | Purpose: drug rash with eosinophilia and systemic symptoms (dress) syndrome is a severe multi-system reaction defined by fever, rash, eosinophilia, and internal organ involvement. |
| PubMedID- 22922763 | The original description involved aromatic anticonvulsants and was termed “anticonvulsant hypersensitivity syndrome.” later the name “drug rash with eosinophilia and systemic symptoms” (dress) was coined but this has been replaced by dihs. |
| PubMedID- 24016284 | Drug rash with eosinophilia and systemic symptoms (dress) is a severe drug-induced hypersensitivity syndrome that presents with diffuse cutaneous eruptions, fever, and multiorgan involvement. |
| PubMedID- 23141052 | Background: drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress) is a serious acute drug reaction with fever, cutaneous eruption, lymphadenopathy, and several visceral dysfunctions. |
| PubMedID- 22511907 | Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis a: a case report. |
| PubMedID- 24912998 | Dress syndrome (drug rash with eosinophilia and systemic symptoms) is an idiosyncratic reaction (type b), characterized by peripheral eosinophilia and systemic symptoms, such as fever, rash, lymphadenopathy, hepatitis, atypical lymphocytes and elevation of liver enzymes at least twice its normal level or increase of alanine amino transferase (alt) >100 u/l. |
| PubMedID- 22744268 | Cases of urticaria, angioedema, anaphylaxis, cytopenia, vasculitis, acute allergic interstitial nephritis, occupational contact dermatitis, photoallergic dermatitis, maculopapular eruption, erythroderma, drug rash with eosinophilia and systemic symptoms (dress) syndrome, stevens-johnson syndrome/toxic epidermal necrolysis, and other autoimmune reactions (including cutaneous lupus erythematosus) have been described. |
| PubMedID- 22224160 | Drug rash with eosinophilia and systemic symptoms (dress) is a rare, severe adverse drug event that appears with a generalized rash, fevers, and dysfunction of 1 or more organ systems. |
| PubMedID- 24958965 | Ticagrelor-induced pneumonitis and subsequent pulmonary hemorrhage; drug rash with eosinophilia due to boceprevir; hepatitis c reactivation after starting infliximab; hydralazine-associated immune glomerulonephritis; fluoroquinolones and retinal detachment. |
| PubMedID- 21998830 | Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7. |
| PubMedID- 20480148 | No cases of onj, stevens–johnson syndrome, or drug rash with eosinophilia and systemic symptoms were found. |
| PubMedID- 23541141 | Introduction: drug rash with eosinophilia and systemic symptoms (dress) syndrome is a drug-induced hypersensitivity syndrome, characterized by rash, hyereosinophilia and multiorgan failure, including cytolytic hepatitis. |
| PubMedID- 23741237 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterized by a severe idiosyncratic reaction including rash and fever, often with associated hepatitis, arthralgias, lymph node enlargement, or hematologic abnormalities. |
| PubMedID- 21219413 | Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin. |
| PubMedID- 24337150 | A dress syndrome (drug rash with eosinophilia and systemic symptoms) was confirmed in accordance with the diagnostic criteria. |